España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Organon
OGN
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$15.49
-0.20
-1.27%
At close: -
$15.54
0.05
0.32%
After Hours: 5:39 PM EDT
Get Report
Comment
The dividend Ex-Date is tomorrow
Organon (OGN) Forecast
News
Earnings
Organon (OGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Organon (NYSE:OGN) Stock
Organon Stock (NYSE: OGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 19, 2025
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Avi Kapoor
Friday, February 14, 2025
Organon & Co. shares are trading lower after ...
Benzinga Newsdesk
Barclays Maintains Overweight on Organon, Low...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Orga...
Benzinga Newsdesk
Thursday, February 13, 2025
Organon shares are trading higher after the c...
Benzinga Newsdesk
Organon Expects 2025 Sales Of $6.125B-$6.325B...
Benzinga Newsdesk
Organon Q4 2024 Adj EPS $0.90 Beats $0.87 Est...
Benzinga Newsdesk
Earnings Scheduled For February 13, 2025
Benzinga Insights
Monday, December 16, 2024
FDA Approves Organon's Vtama (Tapinarof) For ...
Benzinga Newsdesk
Tuesday, December 10, 2024
CNBC Halftime Report Final Trades: Amazon, Or...
Benzinga Newsdesk
Thursday, November 07, 2024
Looking Into Organon's Recent Short Interest
Benzinga Insights
Tuesday, November 05, 2024
Organon & Co shares are trading lower after t...
Benzinga Newsdesk
The FDA Has Extended The Target Action Date O...
Benzinga Newsdesk
Thursday, October 31, 2024
Organon Expects 2024 Adjusted EBITDA Margin O...
Benzinga Newsdesk
Organon Expects 2024 Revenues Of $6.375B-$6.4...
Benzinga Newsdesk
Organon Q3 2024 Adj EPS $0.87 Misses $0.90 Es...
Benzinga Newsdesk
Wednesday, October 30, 2024
Shanghai Henlius Biotech, Organon Report FDA ...
Benzinga Newsdesk
Tuesday, October 22, 2024
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4
Avi Kapoor
Monday, October 21, 2024
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Thursday, October 03, 2024
Organon, Howmet Aerospace And More: CNBC's 'Final Trades'
Avi Kapoor
Wednesday, October 02, 2024
P/E Ratio Insights for Organon
Benzinga Insights
CNBC Halftime Report Final Trades: Organon & ...
Benzinga Newsdesk
Monday, September 30, 2024
Shanghai Henlius Biotech And Organon Announce...
Benzinga Newsdesk
Monday, September 23, 2024
Roivant Sciences And Organon Announce Merger ...
Benzinga Newsdesk
Wednesday, September 18, 2024
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
Vandana Singh
Organon Will Acquire Dermavant, A Roivant Com...
Benzinga Newsdesk
Friday, September 06, 2024
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Vandana Singh
JP Morgan Downgrades Organon to Underweight, ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Organon Has Expanded Its Agreement With Eli L...
Benzinga Newsdesk
Wednesday, August 14, 2024
Is Most-Watched Stock Organon & Co. Worth Betting on Now?
Zacks
Tuesday, August 06, 2024
Organon Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
CNBC Halftime Report Final Trades: Uber Techn...
Benzinga Newsdesk
CORRECTION: Organon & Co. Revises FY24 Revenu...
Benzinga Newsdesk
Organon Q2 2024 Adj. EPS $1.12 Beats $1.08 Es...
Benzinga Newsdesk
Wednesday, July 31, 2024
Is WisdomTree U.S. SmallCap Dividend ETF a Strong ETF Right Now?
Zacks
Tuesday, July 30, 2024
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Avi Kapoor
Thursday, June 13, 2024
Organon & Co. Is a Trending Stock: Facts to Know Before Betting on It
Zacks
Friday, May 24, 2024
Organon Says European Medicines Agency (Ema) ...
Benzinga Newsdesk
Friday, May 10, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Avi Kapoor
Wednesday, May 08, 2024
Reported Earlier, Organon Prices $1B Dual Ser...
Benzinga Newsdesk
Tuesday, May 07, 2024
Organon Announces Proposed $1.0B Senior Notes...
Benzinga Newsdesk
Monday, May 06, 2024
Goldman Sachs Maintains Neutral on Organon, R...
Benzinga Newsdesk
Friday, May 03, 2024
Goldman Sachs Maintains Neutral on Organon, R...
Benzinga Newsdesk
Thursday, May 02, 2024
Organon Beats On Q1, Women's Health Leads the Charge
Lekha Gupta
Organon Reaffirms 2024 Revenues Guidance Of $...
Benzinga Newsdesk
Organon Q1 2024 Adj EPS $1.22 Beats $0.93 Est...
Benzinga Newsdesk
Monday, April 29, 2024
Piper Sandler Maintains Overweight on Organon...
Benzinga Newsdesk
Friday, April 12, 2024
Play Safe! S&P 500 is Teasingly Close to its 50 DMA: 3 Picks
Zacks
Wednesday, April 10, 2024
Is WisdomTree U.S. High Yield Corporate Bond ETF (WFHY) a Strong ETF Right Now?
Zacks
Wednesday, March 13, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
